Concepedia

Publication | Closed Access

Fontolizumab (Huzaf), a humanized anti-IFN-gamma antibody, has clinical activity and excellent tolerability in moderate to severe Crohn’s disease

DOI

36

Citations

0

References

2004

Year

Daniël W. Hommes, Tatiana Mikhajlova, S Stoĭnov, Davor Štimac, Boris Vucelić, János Lonovics, Mária Zakuciová, Geert D’Haens, Gert Van Assche, Tillman Pearce
Gastroenterology

No additional data available for this publication yet. Check back later!